Annexure H – Interest in subsidiary companies, associate and joint ventures

	Shareholding
Subsidiaries	2018 %		2017 %
Adcock Ingram Critical Care Proprietary Limited	100		100
Adcock Ingram Healthcare Proprietary Limited	100		100
Adcock Ingram Intellectual Property Proprietary Limited	100		100
Adcock Ingram International Proprietary Limited	100		100
Adcock Ingram Limited	100		100
Tender Loving Care – Hygienic, Cosmetic and Baby Products Proprietary Limited*	100		100
Joint ventures
Adcock Ingram Limited (India)	49.9		49.9
Thembalami Pharmaceuticals Proprietary Limited*	50		50
Indirect holdings
Adcock Ingram East Africa Limited (Kenya)	100		100
Adcock Ingram Intellectual Property No 1 Proprietary Limited*	100		100
Adcock Ingram Pharmaceuticals Proprietary Limited*	100		100
Addclin Research Proprietary Limited*	100		100
Ayrton Drug Manufacturing Limited (Ghana)	25.1		25.1
Datlabs (Private) Limited (Zimbabwe)	100		100
Dilwed Investments Proprietary Limited	100		100
Genop Holdings Proprietary Limited	100		–
Genop Healthcare Proprietary Limited	100		–
Menarini SA Proprietary Limited**	49		49
Metamorphosa Proprietary Limited*	50		50
National Renal Care Proprietary Limited	50		50
Novartis Ophthalmics Proprietary Limited**	49		49
Pharmalabs (Jersey) Limited	100		100
Premier Pharmaceutical Company Proprietary Limited*	100		100
Relicare Tech Services Private Limited (India)	100		100
Virtual Logistics Proprietary Limited	100		100
Trusts and structured entities
AdBEE (RF) Limited***
Adcock Ingram Holdings Limited Employee Share Trust (2008)
Ad-Izinyosi (RF) Proprietary Limited***
Mpho ea Bophelo Trust
39 Owner-driver companies (2017: 28 companies)

*	Dormant entities.
**	Regarded as subsidiaries and consolidated.
***	Not consolidated